ClinConnect ClinConnect Logo
Search / Trial NCT03803852

Rotation of Hydrophobic Acrylic Lenses - Rayner RA0800C & Alcon Clareon & Hoya Nanex & Hoya Vivinex XY1-EM & RayOne EMV Toric & PODEYE Toric

Launched by MEDICAL UNIVERSITY OF VIENNA · Jan 10, 2019

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying different types of intraocular lenses (IOLs) used during cataract surgery to see how well they work for patients with age-related cataracts and astigmatism. The trial will look at three specific lenses: Rayner RA0800C, Alcon Clareon, and Hoya Nanex & Vivinex XY1-EM. If you are between the ages of 45 and 95 and need cataract surgery, you may be eligible to participate. You should have certain levels of astigmatism and need specific degrees of lens correction.

As a participant, after you agree to join the study, you will undergo cataract surgery, where the IOL will be implanted. Following the surgery, you will have several check-ups at different times to assess your vision and the position of the lens. It's important to note that some individuals, like those with certain eye conditions or health issues, won't qualify for this trial. This study aims to help improve options for people needing cataract surgery, and your involvement could contribute to better treatments in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Uni- or bilateral age-related cataract necessitating phacoemulsification extraction and posterior IOL implantation
  • Age: 45 to 95
  • Need for spherical IOL correction between 10.00 and 30.00 D
  • Need for spherical IOL correction between +6.00 and +30.00 D (Alcon Clareon toric group)
  • Need for spherical IOL correction between +10.00 and +25.00 D (Rayner RayOne EMV toric group)
  • Preoperative pupil dilation in mydriasis ≥ 7.0 mm (Hoya, Rayner groups)
  • Astigmatism of at least 1.0 Diopters (Alcon Clareon toric and Rayner RayOne EMV toric groups and PODEYE Toric)
  • Pupil dilation \>5.5mm (Alcon Clareon toric Rayner RayOne EMV toric group)
  • Exclusion Criteria:
  • Preceding ocular surgery or trauma
  • Recurrent intraocular inflammation of unknown etiology
  • Uncontrolled glaucoma
  • Uncontrolled systemic or ocular disease
  • Blind fellow eye
  • Microphthalmus
  • Corneal abnormality (Corneal scaring)
  • History of uveitis/iritis
  • Iris neovascularization
  • Proliferative diabetic retinopathy
  • Pregnancy
  • Lactation
  • Females of childbearing age will be asked if pregnancy is possible

About Medical University Of Vienna

The Medical University of Vienna is a leading research institution dedicated to advancing healthcare through innovative clinical research and education. Renowned for its commitment to excellence in medical science, the university fosters interdisciplinary collaboration among researchers, clinicians, and academic professionals. Its clinical trials encompass a wide range of medical disciplines, aiming to develop cutting-edge therapies and improve patient outcomes. With state-of-the-art facilities and a strong emphasis on ethical standards, the Medical University of Vienna is at the forefront of transforming scientific discoveries into practical applications that enhance global health.

Locations

Vienna, , Austria

Patients applied

0 patients applied

Trial Officials

Rupert Menapace, Prof.Dr.

Principal Investigator

Medical University Vienna

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials